Authors
Latest:
Using Digital Media to Counsel PatientsAdvancements in our ability to care for patients have enabled us to control and sometimes cure many diseases.
Latest:
The Evolving Epilepsy Treatment Spectrum: A Review of Antiepileptic Drugs in Late DevelopmentGiven the relatively static rate of seizure freedom with the current antiepileptic drug (AED) armamentarium, a need remains for the development of new compounds to help enable more patients achieve seizure freedom. Fortunately, several investigational therapeutic agents and delivery systems are in phase 3 development, which are being investigated for the treatment of orphan diseases and focal-onset and generalized-onset seizures.
Latest:
Medication Adherence: A Vital Portion of the Treatment PlanNon-adherence to medications is one of the country's largest and most expensive disease categories. Specialty pharmacists play a vital role in improving adherence.
Latest:
Tech Duties Increase in Health SystemsTechnicians pick up administrative tasks so pharmacists can spend more time on direct patient care.
Latest:
Rehospitalizations and Direct Medical Costs for cSSSI: Linezolid Versus VancomycinAmong commercially insured patients treated with linezolid or vancomycin following cSSSI-related hospitalization, linezolid was associated with significantly lower rehospitalization rates and total direct medical costs.
Latest:
New Combination Therapies for the Treatment of Chronic Lymphocytic LeukemiaPatients with CLL may have genetic mutations that predict response to different treatments.
Latest:
Driving Patient Adherence (and Outcomes) Through Appointment-Based Refill ProgramsOne of the biggest struggles facing patients today is ensuring they have the proper medications on hand and that they are taking their medications correctly.
Latest:
Recent Trends in the Treatment of Chronic Hepatitis CThis article is an early utilization review of newer, more effective, and more costly regimens for the treatment of hepatitis C.
Latest:
Cost-Utility Analysis of Treatments for Advanced Non-Small Cell Lung CancerA national community-level study of Medicare patients with advanced non-small cell lung cancer found that adding targeted therapy to chemotherapy regimens was not cost-effective.
Latest:
Patient Engagement Strategies for Immunization in a Community Pharmacy SettingPrior to vaccines, immunity to a disease was acquired solely through contracting the illness.
Latest:
The Role of Pharmacy Benefit Mangers in American Health Care: Pharmacy Concerns and Perspectives: Part 3There have been multiple concerns levied about PBM tactics that have led plan sponsors and pharmacy stakeholders to push back.
Latest:
Oxybutynin May Provide Hot Flash Treatment Option in Breast Cancer SurvivorsHot flashes are a huge problem across the general population, but even more so in breast cancer survivors.
Latest:
The Challenges and Rewards of Launching an Orphan DrugWith orphan drugs under the microscope, it's important to review the special circumstances and challenges of this group.
Latest:
Pharmacologic Treatment Challenges for IBDIrritable bowel disease, which is defined as chronic idiopathic inflammation of the digestive tract, affects 3.1 million adults in the United States.
Latest:
Economic Burden of Oral Tyrosine Kinase Inhibitors Among Privately Insured Patients Diagnosed With Metastatic Renal Cell CarcinomaStudy investigate the economic burden from the total costs, private insurance reimbursement, and out-of-pocket costs for oral TKI agents among metastatic RCC patients.
Latest:
Fostering Rapid Innovation During a Time of CrisisPromoting an environment that allows for rapid problem-solving and execution under high stress is essential to face problems that are poorly understood and yet require rapid change.
Latest:
New Treatment for Progressive Multiple Sclerosis on the HorizonRelationship between MS and common herpes virus Epstein-Barr virus offer new treatment target.
Latest:
Presidential Candidate's Disclosure of Migraine Helps Increase AwarenessDiscussion around Michele Bachmann's condition has brought migraine management to the forefront.
Latest:
Drug Combination Leads to Progression-Free Survival in Patients With CancerA randomized clinical trial offers strong evidence that a combination of 2 targeted melanoma drugs when given continuously keeps cancer from growing or spreading longer compared with intermittent treatment.
